Brokerages expect HCP, Inc. (NYSE:HCP) to post earnings of $0.44 per share for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for HCP’s earnings. The lowest EPS estimate is $0.42 and the highest is $0.44. HCP posted earnings per share of $0.48 during the same quarter last year, which would suggest a negative year over year growth rate of 8.3%. The business is scheduled to announce its next earnings report on Tuesday, February 12th.
According to Zacks, analysts expect that HCP will report full year earnings of $1.82 per share for the current fiscal year, with EPS estimates ranging from $1.80 to $1.83. For the next fiscal year, analysts expect that the company will report earnings of $1.79 per share, with EPS estimates ranging from $1.69 to $1.84. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that cover HCP.
HCP (NYSE:HCP) last posted its earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.11 by $0.10. The company had revenue of $456.00 million for the quarter, compared to analysts’ expectations of $456.59 million. HCP had a return on equity of 3.06% and a net margin of 9.16%. HCP’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the firm earned $0.48 earnings per share.
Several analysts recently issued reports on the company. BMO Capital Markets reissued a “hold” rating and issued a $27.00 target price on shares of HCP in a research note on Wednesday, October 31st. Morgan Stanley raised their target price on HCP from $23.50 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 16th. Robert W. Baird raised their target price on HCP from $24.00 to $26.00 and gave the stock a “neutral” rating in a research note on Thursday, August 9th. Cantor Fitzgerald assumed coverage on HCP in a research note on Tuesday, August 7th. They issued a “neutral” rating and a $28.00 target price on the stock. Finally, Zacks Investment Research raised HCP from a “sell” rating to a “hold” rating in a research note on Tuesday, August 7th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the company. HCP has an average rating of “Hold” and an average target price of $26.75.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Mount Yale Investment Advisors LLC purchased a new position in HCP in the 2nd quarter worth approximately $104,000. Piedmont Investment Advisors LLC purchased a new position in HCP in the 2nd quarter worth approximately $142,000. Peoples Financial Services CORP. raised its holdings in HCP by 87.7% in the 3rd quarter. Peoples Financial Services CORP. now owns 6,100 shares of the real estate investment trust’s stock worth $161,000 after acquiring an additional 2,850 shares during the last quarter. Wetherby Asset Management Inc. purchased a new position in HCP in the 3rd quarter worth approximately $200,000. Finally, Lourd Capital LLC purchased a new position in HCP in the 3rd quarter worth approximately $211,000. Institutional investors own 87.64% of the company’s stock.
Shares of NYSE HCP traded up $0.05 during trading hours on Friday, hitting $28.82. The company’s stock had a trading volume of 3,877,224 shares, compared to its average volume of 3,960,649. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.48 and a quick ratio of 0.48. The stock has a market capitalization of $13.50 billion, a PE ratio of 14.78, a PEG ratio of 7.21 and a beta of 0.16. HCP has a 12 month low of $21.48 and a 12 month high of $28.92.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 20th. Investors of record on Monday, November 5th will be issued a $0.37 dividend. The ex-dividend date of this dividend is Friday, November 2nd. This represents a $1.48 dividend on an annualized basis and a yield of 5.14%. HCP’s payout ratio is currently 75.90%.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Recommended Story: Hedge Funds – How They Work For Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.